For the Inventor, By the Inventor

Enter assignee name

Blaubeuren, Germany

Merckle Gmbh

Calculating rank

USPTO Granted Patents = 26

% Expired Patents = 42.3

EPO Patents = 3

Forward Citations = 240

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Stefan Laufer (12 out of 22 patents)

Hans-Guenter Striegel (6 out of 6 patents)

Gerd Dannhardt (5 out of 13 patents)

4. Karola Tollmann (5 out of 6 patents)

5. Philipp Merckle (4 out of 4 patents)

6. Gunter Metz (4 out of 8 patents)

7. Thomas Kammermeier (3 out of 3 patents)

8. Matthias Lehr (3 out of 3 patents)

9. Kurt Rauchle (3 out of 3 patents)

10. Hans Gunther Striegel (3 out of 3 patents)

11. Wolfgang Albrecht (2 out of 44 patents)

12. Susanne Tries (2 out of 2 patents)

13. Eberhard P Hofer (2 out of 2 patents)

14. Christian Rembe (2 out of 2 patents)

15. Manfred Erdmann (1 out of 3 patents)

Core Competencies:

Pyrrole Derivatives

2-Thio-Substituted Imidazoles

Antibiotic Conjugates

Anti-Inflammatory Agents

Tissue Factor

Macromolecule Synthesis

CD 137

Flufenamic Acid

Liquid Diclofenac

Injectable Solutions

26 patents: Sort by Forward Citations

1. 8034837 - Polymorphic form of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid (2011-10-11),

2. 7608633 - [object Object] (2009-10-27),

3. 7442713 - 2-thio-substituted imidazole derivatives and their use in pharmaceutics (2008-10-28),

4. 7425573 - Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration (2008-09-16),

5. 7271154 - Antibiotic conjugates (2007-09-18),

6. 7253191 - 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry (2007-08-07),

7. 7078535 - Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid (2006-07-18),

8. 6936632 - Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof (2005-08-30),

9. 6930094 - Tissue factor for influencing blood vessel formation (2005-08-16),

10. 6878738 - Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use (2005-04-12),

11. 6867211 - 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy (2005-03-15),

12. 6627200 - Utilization of CD 137 in order to promote the proliferation of peripheral monocytes (2003-09-30),

13. 6544775 - Automated macromolecule synthesizing process and device (2003-04-08),

14. 6505914 - Microactuator based on diamond (2003-01-14),

15. 6432988 - 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine (2002-08-13),

Company Overview

Merckle GmbH, based in Blaubeuren, Germany, is a prominent player in the pharmaceutical and healthcare sectors. The company specializes in the development and manufacturing of high-quality generic medications, focusing on providing accessible healthcare solutions. With a commitment to innovation, Merckle engages in extensive research and development activities, particularly in the fields of oncology, cardiology, and central nervous system disorders. Its strategic initiatives aim to enhance therapeutic options and improve patient outcomes globally.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

26 Patents

#1 in Blaubeuren

#1,788 in Germany

#24,826 in the World

Blaubeuren, Germany

Merckle Gmbh

Forward Citations = 240

42 inventors:

Stefan Laufer (12 out of 22 patents)

Hans-Guenter Striegel (6 out of 6 patents)

Gerd Dannhardt (5 out of 13 patents)

4. Karola Tollmann (5 out of 6 patents)

5. Philipp Merckle (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Merckle Gmbh. Retrieved from https://idiyas.com/company/merckle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…